Список проголосовавших за комментарий "Gapping up<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>NEPT</strong> +13.8%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>P</strong> +7.8% (Sirius XM (SIRI) might be interested in acquiring Pandora, according to NY Post, also expects to exceed Q4 guidance)</li><li><strong>SN</strong> +7.8% (Anadarko Petroleum to sell Eagleford Shale assets in South Texas for approx $2.3 bln to Sanchez Energy and Blackstone Group),</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>RXII</strong> +40.4% (OPKO Health (OPK) increases stake to 5.11% (Prior 3.43%), changes shareholding position to passive from active)</li><li><strong>TBIO</strong> +27.7% (continued momentum)</li><li><strong>TTNP</strong> +22% ( CMC has granted a opermanent J-code for Probuphine)</li><li><strong>IOTS</strong> +5.3% (after ~50% move higher on Thursday)</li><li><strong>OPXA</strong> +5.2% (following late move higher into the close)</li><li><strong>OREX</strong> +4.4% (after spiking higher into the close)</li><li><strong>NVLS</strong> +4.1% (approved a restructuring plan as part of the Company's initiative to explore strategic alternatives; cutting 25 of 30 emplyees, including the CEO and CMO)</li><li><strong>IMMU</strong> +3.8% (continued momentum)</li><li><strong>ZIOP</strong> +3.6% ( following Najarian mention on CNBC)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>MBLY</strong> +2.8% (initiated with a Buy at Jefferies)</li><li><strong>GRUB</strong> +2.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley)</li><li><strong>CNHI</strong> +2% (upgraded to Neutral from Underperform at BofA/Merrill )</li><li><strong>NOK</strong> +1.5% (upgraded to Buy from Neutral at Natixis)</li><li><strong>NFLX</strong> +1.2% (upgraded to Hold at Deutsche Bank)</li><li><strong>CIEN</strong> +0.7% (initiated with a Buy at UBS)</li><li><strong>FB</strong> +0.7% (upgraded to Strong Buy from Outperform at Raymond James)</li></ul>"